Literature DB >> 20577834

C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation.

Mats Remberger1, Jonas Mattsson.   

Abstract

The prognostic value of CRP levels before conditioning for allogeneic stem-cell transplantation (ASCT) was evaluated. Reduced-intensity conditioning (RIC) was given to 205 patients and conventional myeloablative conditioning (MAC) to 299 patients. Most patients had an HLA-compatible related or unrelated donor. There were 287 males and 216 females, median age 36 (1-69) years. Most patients received peripheral blood stem cells. Increased CRP levels (>10 mg/L) were detected in 129 patients (26%). Overall survival (OS) and transplant-related mortality (TRM) were worse for RIC patients with elevated CRP (67 vs. 43%, p = 0.005, and 16 vs. 30%, p = 0.036) while no difference was seen in MAC patients. An infection at the start of conditioning was seen in 27 RIC patients. We identified a subgroup of patients with an infection and elevated CRP (n = 16) and these patients had the worst outcome. In multivariate analysis, both infection and elevated CRP was the strongest factor associated with OS (HR 3.27, p < 0.001) and TRM (HR 4.35, p < 0.001). No correlation between any outcome variable and CRP was seen in MAC-treated patients. CRP may be a good prognostic factor for outcome after RIC and ASCT. It should be analyzed before conditioning, especially in patients with coexisting infection since patients with increased CRP and infection seem to have a very poor outcome after ASCT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577834     DOI: 10.1007/s12185-010-0632-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

Review 1.  Specific infectious complications after stem cell transplantation.

Authors:  Holger Hebart; Hermann Einsele
Journal:  Support Care Cancer       Date:  2003-08-15       Impact factor: 3.603

Review 2.  Hematopoietic stem-cell transplantation.

Authors:  Edward A Copelan
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

3.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

4.  Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.

Authors:  Ulrica Forslöw; Jonas Mattsson; Olle Ringden; Julius Klominek; Mats Remberger
Journal:  Scand J Infect Dis       Date:  2006

5.  Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.

Authors:  Mehmet Uzunel; Mats Remberger; Darius Sairafi; Zuzana Hassan; Jonas Mattsson; Brigitta Omazic; Lisbeth Barkholt; Olle Ringdén
Journal:  Transplantation       Date:  2006-10-15       Impact factor: 4.939

6.  Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.

Authors:  Frédéric Baron; Barry Storer; Michael B Maris; Jan Storek; Fanny Piette; Monja Metcalf; Kristen White; Brenda M Sandmaier; David G Maloney; Rainer Storb; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2006-11       Impact factor: 5.742

7.  Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation.

Authors:  Mats Remberger; Britt-Marie Svahn; Jonas Mattsson; Olle Ringdén
Journal:  Transplantation       Date:  2004-07-15       Impact factor: 4.939

8.  The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumonia.

Authors:  U Forslöw; M Remberger; A Nordlander; J Mattsson
Journal:  Bone Marrow Transplant       Date:  2009-09-28       Impact factor: 5.483

9.  Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.

Authors:  Andrew S Artz; Amittha Wickrema; Shira Dinner; Lucy A Godley; Masha Kocherginsky; Olatoyosi Odenike; Elizabeth S Rich; Wendy Stock; Jodie Ulaszek; Richard A Larson; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2008-11       Impact factor: 5.742

10.  C-reactive protein in viral and bacterial respiratory infection in children.

Authors:  M Korppi; L Kröger
Journal:  Scand J Infect Dis       Date:  1993
View more
  7 in total

1.  High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.

Authors:  Yago Nieto; Peter Thall; Ben Valdez; Borje Andersson; Uday Popat; Paolo Anderlini; Elizabeth J Shpall; Roland Bassett; Amin Alousi; Chitra Hosing; Partow Kebriaei; Muzaffar Qazilbash; Erin Frazier; Alison Gulbis; Christina Chancoco; Qaiser Bashir; Stefan Ciurea; Issa Khouri; Simrit Parmar; Nina Shah; Laura Worth; Gabriela Rondon; Richard Champlin; Roy B Jones
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-27       Impact factor: 5.742

2.  Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT.

Authors:  Aliénor Xhaard; Renato Cunha; Marc Busson; Marie Robin; Nathalie Dhedin; Tereza Coman; Aurélie Cabannes-Hamy; Flore Sicre de Fontbrune; David Michonneau; Gérard Socié; Rodrigo T Calado; Régis Peffault de Latour
Journal:  Blood Adv       Date:  2017-08-02

Review 3.  Stem cell transplantation for indolent lymphoma: a reappraisal.

Authors:  Koen van Besien
Journal:  Blood Rev       Date:  2011-09       Impact factor: 8.250

4.  Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Soichiro Sakamoto; Hiroshi Kawabata; Junya Kanda; Tatsuki Uchiyama; Chisaki Mizumoto; Tadakazu Kondo; Kouhei Yamashita; Tatsuo Ichinohe; Takayuki Ishikawa; Norimitsu Kadowaki; Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2012-12-07       Impact factor: 2.490

5.  Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.

Authors:  Wataru Yamamoto; Eriko Fujii; Kenji Matsumoto; Eri Yamamoto; Jun Aoki; Masatsugu Tanaka; Yoshiaki Ishigatsubo; Heiwa Kanamori
Journal:  Int J Hematol       Date:  2016-01-20       Impact factor: 2.490

6.  Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation.

Authors:  Tor Henrik Tvedt; Stein Atle Lie; Håkon Reikvam; Kristin Paulsen Rye; Roald Lindås; Tobias Gedde-Dahl; Aymen Bushra Ahmed; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2016-11-01       Impact factor: 5.923

Review 7.  Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.

Authors:  Tor Henrik Anderson Tvedt; Elisabeth Ersvaer; Anders Aune Tveita; Øystein Bruserud
Journal:  Front Immunol       Date:  2017-06-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.